IntelGenx Technologies Corp. (IGX) Analysts See $-0.02 EPS; Shorts at Enlink Midstream Llcunits Representing LI (ENLC) Lowered By 4.75%

April 17, 2018 - By Clifton Ray

EnLink Midstream, LLC (NYSE:ENLC) Logo

Enlink Midstream Llcunits Representing LI (NYSE:ENLC) had a decrease of 4.75% in short interest. ENLC’s SI was 5.32M shares in April as released by FINRA. Its down 4.75% from 5.58M shares previously. With 415,600 avg volume, 13 days are for Enlink Midstream Llcunits Representing LI (NYSE:ENLC)’s short sellers to cover ENLC’s short positions. The SI to Enlink Midstream Llcunits Representing LI’s float is 8.53%. The stock increased 0.17% or $0.025 during the last trading session, reaching $14.925. About 533,154 shares traded or 37.35% up from the average. EnLink Midstream, LLC (NYSE:ENLC) has declined 21.83% since April 17, 2017 and is downtrending. It has underperformed by 33.38% the S&P500.

Analysts expect IntelGenx Technologies Corp. (CVE:IGX) to report $-0.02 EPS on May, 10.They anticipate $0.01 EPS change or 100.00% from last quarter’s $-0.01 EPS. After having $-0.03 EPS previously, IntelGenx Technologies Corp.’s analysts see -33.33% EPS growth. The stock increased 1.25% or $0.01 during the last trading session, reaching $0.81. About 2,500 shares traded. IntelGenx Technologies Corp. (CVE:IGX) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 21 analysts covering EnLink Midstream LLC (NYSE:ENLC), 3 have Buy rating, 3 Sell and 15 Hold. Therefore 14% are positive. EnLink Midstream LLC had 71 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was downgraded by Jefferies on Wednesday, June 8 to “Hold”. The firm earned “Hold” rating on Monday, April 24 by RBC Capital Markets. The firm has “Underperform” rating by Jefferies given on Thursday, January 12. The firm has “Overweight” rating by Barclays Capital given on Thursday, February 18. Goldman Sachs downgraded EnLink Midstream, LLC (NYSE:ENLC) on Monday, September 19 to “Sell” rating. Jefferies maintained it with “Hold” rating and $16.0 target in Friday, January 12 report. Citigroup initiated it with “Buy” rating and $31 target in Tuesday, August 11 report. The company was reinitiated on Friday, April 1 by Piper Jaffray. The firm has “Neutral” rating by Bank of America given on Thursday, February 22. RBC Capital Markets maintained EnLink Midstream, LLC (NYSE:ENLC) rating on Thursday, February 18. RBC Capital Markets has “Sector Perform” rating and $10 target.

EnLink Midstream, LLC gathering, transmission, processing, fractionation, storage, stabilization, brine, and marketing services to producers of natural gas, natural gas liquids, crude oil, and condensate in the United States. The company has market cap of $2.70 billion. The Company’s midstream energy asset network includes approximately 11,000 miles of pipelines; 20 natural gas processing plants; 7 fractionators; barge and rail terminals; product storage facilities; brine disposal wells; and a crude oil trucking fleet. It has a 12.92 P/E ratio. The firm was founded in 2013 and is headquartered in Dallas, Texas.

IntelGenx Technologies Corp., a drug delivery company, develops novel oral immediate-release and controlled-release products for the pharmaceutical market. The company has market cap of $56.25 million. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. It currently has negative earnings. The company's products under development comprise INT0001/2004, an anti-hypertension drug; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2012 for schizophrenia; and INT0043/2015 to treat mild cognitive impairment and Alzheimer's disease.

EnLink Midstream, LLC (NYSE:ENLC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>